Indian Journal of Pharmaceutical Sciences
Users online: 46
Scientific Publication of the Indian Pharmaceutical Association
Home Email this page Print this page Bookmark this page Decrease font size Default font size Increase font size
The Journal Search Current Issue Archives Instructions Online submission Login  


 
SHORT COMMUNICATION
Year : 2009  |  Volume : 71  |  Issue : 4  |  Page : 477-480
Simultaneous RP-HPLC and HPTLC estimation of fluoxetine hydrochloride and olanzapine in tablet dosage forms


S. K. Patel College of Pharmaceutical Education and Research, Department of Pharmaceutical Chemistry, Ganpat University, Kherva, Mehsana-382711, India

Date of Submission24-Jun-2008
Date of Decision20-May-2009
Date of Acceptance15-Aug-2009
Date of Web Publication28-Oct-2009

Correspondence Address:
Sejal Patel
S. K. Patel College of Pharmaceutical Education and Research, Department of Pharmaceutical Chemistry, Ganpat University, Kherva, Mehsana-382711
India
Login to access the Email id


DOI: 10.4103/0250-474X.57306

PMID: 20502563

Get Permissions

   Abstract 

A binary mixture of fluoxetine HCl and olanzapine was determined by two different methods. The first method involved determination of fluoxetine HCl and olanzapine using reversed-phase liquid chromatography using acetonitrile:methanol:0.032 M ammonium acetate buffer (45:05:50, v/v/v) as the mobile phase at a flow rate of 1.5 ml/min. Quantitation was achieved with ultraviolet detection at 235 nm over concentration ranges of 0.2-4 and 0.1-2 μg/ml; mean accuracies were 101.16±0.59 and 99.79±0.56% for fluoxetine HCL and olanzapine, respectively. The second method was based on the high performance thin layer chromatography separation of the two drugs followed by densitometric measurements of their spots at 235 nm. The separation was carried out on Merck TLC aluminium sheets of silica gel 60 F254 using acetone:methanol:triethyleamine (5:3:0.5, v/v/v), as mobile phase. The linearity was found to be in the range of 300-1000 and 150-500 ng/spot; mean accuracies were 100.95±0.52 and 99.31±0.51% for fluoxetine HCl and olanzapine, respectively. The method was successively applied to tablets because no chromatographic interferences from the tablet excipients were found. The methods retained their accuracy and precision when the standard addition technique was applied. The results obtained by applying the proposed methods were statistically analyzed.


Keywords: Fluoxetine HCl, olanzapine, RP-HPLC, HPTLC, simultaneous estimation


How to cite this article:
Patel S, Patel N J. Simultaneous RP-HPLC and HPTLC estimation of fluoxetine hydrochloride and olanzapine in tablet dosage forms. Indian J Pharm Sci 2009;71:477-80

How to cite this URL:
Patel S, Patel N J. Simultaneous RP-HPLC and HPTLC estimation of fluoxetine hydrochloride and olanzapine in tablet dosage forms. Indian J Pharm Sci [serial online] 2009 [cited 2015 Jan 29];71:477-80. Available from: http://www.ijpsonline.com/text.asp?2009/71/4/477/57306


Fluoxetine HCl (FLX) is chemically, N-Methyl-γ-[4-(trifluoromethyl) phenoxy benzenpropanamine hydrochloride[1] . Fluoxetine hydrochloride is a selective serotonin reuptake inhibitor used as an antidepressant with non-sedating properties [2] . Olanzapine (OLZ) is chemically , 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno [2,3-b] [1,5]-benzodiazepine [1] . It is an antipsychotic agent, used in schizophrenia [2] . FLX is official in BP and USP and both describe an LC method for the estimation of fluoxetine [3],[4] . A literature survey indicated spectrophotometric methods of FLX in formulations [5],[6],[7] ; HPLC [8],[9],[10] and LC-MS [11] methods of FLX with norfluoxetine in plasma. Literature survey also indicated HPLC [12] , HPLC-MS/ESI [13] , capillary GC [14] methods for simultaneous estimation of FLX in pharmaceutical formulation with drugs like fluvoxamine, clomipramine, citalopram and paroxetine. OLZ is official in IP [15] , which described an HPLC method for its estimation. Literature survey indicated spectrophotometric [16] , derivative spectroscopy [17] and solid phase extraction [18] methods for estimation of OLZ. Literature survey also indicated HPLC [19],[20] and LC-MS [21] methods for determination of OLZ in biological fluids. FLX and OLZ are formulated together in the form of a tablet. Literature survey revealed two methods [22],[23] for simultaneous determination of these two drugs. The methods presently developed have the advantage of being more sensitive to determine both drugs concurrently by simple, accurate, rapid and precise RP-HPLC and HPTLC assays for routine analysis.

For the RP-HPLC method, the chromatography was performed on a Shimadzu (Columbia, MD) RP-HPLC instrument (LC-10AT vp) equipped with UV/Vis detector, manual injector with 20 μl volume injection loop. A Phenomenex (Torrance, CA) C18 column (250Χ4.6 mm id, 5 μm particle size) was used as stationary phase. For HPTLC method, a Camag system comprising of Linnomat V automatic sample applicator, Camag microlitre syringe, Camag TLC Scanner-3, Camag Win CAT software and a stationary phase precoated silica gel 60F 254 were used. CP224S analytical balance (Sartorius) and ultra sonic cleaner (Frontline FS 4) were used. Pure samples of FLX and OLZ were kindly supplied by Intas Pharmaceuticals Ltd., Ahmedabad, India. Samples of Oleanz Fort tablets, marketed by Sun Pharmaceuticals Ltd., with each tablet containing 20 mg FLX and 10 mg OLZ were used. Triple distilled water, methanol, acetonitrile (HPLC grade), ammonium acetate, acetone, methanol, triethylamine (AR grade) were procured from S. D. Fine Chemicals, Ahmedabad, India.

For the RP-HPLC method, FLX and OLZ stock solutions (200 μg/ml and 100 μg/ml, respectively) were prepared in methanol. From these stock solutions working solutions (5 μg/ml and 2.5 μg/ml) were prepared. Accurate aliquots equivalent to 0.2-4 μg FLX from its working solution (5 μg/ml) and aliquots equivalent to 0.1-2 μg OLZ from its working solution (2.5 μg/ml) were transferred into two separate sets of 5 ml volumetric flasks and diluted to volume with methanol. Using the Shimadzu instrument, chromatograms were recorded using instrument parameters such as 1.5 ml/min flow rate at ambient temperature and the eluent monitored at 235 nm. The separation was done on a C18 column using acetonitrile:methanol:0.032 M ammonium acetate buffer (45:05:50, v/v/v) as the mobile phase. Calibration curves for both FLX and OLZ were plotted, and the corresponding regression equations were calculated.

For the HPTLC method, FLX and OLZ stock solutions (500 μg/ml and 250 μg/ml) were prepared in methanol. From these stock solutions working solutions (100 μg/ml and 50 μg/ml) were prepared. Different volumes of the working solutions (3, 4, 5, 6, 7, 8, 9 and 10 μl, equivalent to 300, 400, 500, 600, 700, 800, 900 and 1000 ng/spot of FLX and 150, 200, 250, 300, 350, 400, 450 and 500 ng/spot of OLZ) were applied, in triplicate, to the TLC plate, as bands of 5 mm width using a Camag (Switzerland) Linomat V sample applicator fitted with a Camag microlitre syringe. A constant application rate of 0.1μl/s was used. Linear ascending development of the plates to a distance of 8 cm was performed with acetone:methanol:triethyleamine (5:3:0.5, v/v/v), as the mobile phase in a twin-trough glass chamber previously saturated with mobile phase vapour for 20 min at room temperature (25°). After development the plate was scanned at 235 nm by means of a Camag TLC scanner-3 in absorbance mode, using the deuterium lamp. The slit dimensions were 5Χ0.45 mm and the scanning speed was 10 mm/s. After development peak area data and drug concentration data were treated by linear regression to determine linearity.

Powder from the mixed contents of 20 tablets, equivalent to 20 mg FLX and 10 mg OLZ, was transferred accurately to 50 ml volumetric flask and diluted to volume with methanol. The solution was diluted to the same concentrations of working standard solutions and treated according to the linearity for the RP-HPLC and HPTLC methods.

A simple RP-HPLC method was adopted for the simultaneous determination of FLX and OLZ either in bulk powder or in pharmaceutical formulation. The best resolution was achieved using a mobile phase consisting of acetonitrile:methanol:0.032 M ammonium acetate buffer (45:05:50, v/v/v), which gave good resolution and sensitivity of both drugs [Figure 1]. A linear relation was obtained between peak area and the concentration of the two drugs in the range of 0.2-4 and 0.1-2 μg/ml for FLX and OLZ, respectively. The linear regression equations were computed as: Y= 304092X-15556, r= 0.9993 and Y= 749978X+51394, r= 0.9973, where Y is the area under the peak, X is the concentration in μg/ml, and r is the correlation coefficient. System suitability testing of the RP-HPLC method gave good relative retention time = 1.95; Theoretical plates = 6162.17 and 10002.17; Asymmetry factor (A)= 1.42 and 1.24; and tailing factor (T)= 1.32 and 1.15 for FLX and OLZ, respectively [Table 1].

To optimize the HPTLC parameters, several mobile phase compositions were tried. Acetone:methanol:triethyleamine (5:3:0.5, v/v/v), gave a sharp and symmetrical peaks of FLX and OLZ with Rf values of 0.58±0.02 and 0.77±0.01, respectively [Figure 2]. Well-defined spots (and peaks) were obtained when the chamber was saturated with mobile phase vapour for 20 min at room temperature (25°). A linear relation was obtained between peak area and the concentration of the two drugs in the range of 300-1000 ng/spot and 150-500 ng/spot for FLX and OLZ, respectively. The linear regression equations were computed as: Y= 4.4869X+182.44, r= 0.9961 and Y= 11.836X+32.073, r= 0.9964, where Y is the area under the peak, X is the concentration in μg/ml, and r is the correlation coefficient.

Results obtained by applying the RP-HPLC and HPTLC procedures showed that both the drugs can be simultaneously analyzed in the prepared mixtures with mean recoveries of 101.16±0.59 and 99.79±0.56%; 100.95±0.52 and 99.31±0.51%, respectively [Table 2]. The proposed method has been applied to assay FLX and OLZ in tablets without any interference from the additives [Table 3]. The results of assay validation of the proposed methods show that they are accurate and precise according to the RSD values of intra and interday determinations [Table 4].

The assay results for FLX and OLZ in their tablet dosage form obtained using the RP-HPLC and HPTLC methods were compared by applying the paired t-test. The calculated t-values 0.60 for FLX and 0.49 for OLZ are less than the tabulated t-value (3.82) at the 98% confidence interval. Therefore, there is no significant difference in a determined content of FLX and OLZ by the RP-HPLC and HPTLC methods. The proposed procedures can be applied for the simultaneous determination of FLX and OLZ. Moreover, the methods are rapid, sensitive, accurate, precise and can be used in routine analysis.


   Acknowledgements Top


The authors are thankful to Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat Vidyanagar, Kherva, Mehsana for providing facilities to carry out the work.

 
   References Top

1.O'Neil MJ. The Merck Index. 14th ed. Whitehouse Station, NJ: Merck& Co. Inc.; 2006. p. 741, 1220.  Back to cited text no. 1      
2.Mishra L. Drug Today. Vol. 1. Delhi: Lorina Publications Inc; April-June 2006. p. 480, 490.  Back to cited text no. 2      
3.British Pharmacopoeia. Vol. 1. London: Her Majesty's Stationary Office; 2005. p. 860.  Back to cited text no. 3      
4.The United States Pharmacopoeia. 28th Rev. Rockville MD: U.S. Pharmacopoeial Convention. Inc; 2005. p. 853.  Back to cited text no. 4      
5.Bebawy LI, El-Kousy N, Suddik JK, Shokry M. Spectrophotometric determination of fluoxetine and sertraline using chloranil, 2,3-dichloro-5,6-dicyanobenzoquinone and iodine. J Pharm Biomed Anal 1999;21:133-42.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]  
6.Abbas A, Tayyebeh M, Lida K. Spectrophotometric determination of fluoxetine by batch and flow injection methods. Chem Pharm Bull 2006;54:1642-6.  Back to cited text no. 6      
7.Naik MT, Rokade MD, Dhadke PM. Extractive spectrophotometric estimation of fluoxetine hydrochloride in pharmaceutical formulations. Indian J Pharm Sci 1999;61:156-7.  Back to cited text no. 7      
8.Peyton AL, Carpenter R, Rutkowski K. The stereospecific determination of fluoxetine and norfluoxetine enantiomers in human plasma by high-pressure liquid chromatography (HPLC) with fluorescence detection. Indian J Pharm Sci 1991;8:1528- 32.  Back to cited text no. 8      
9.Raggi MA, Mandrioli R, Casamenti G, Volterra V, Desiderio C, Fanali S. Improved HPLC determination of fluoxetine and norfluoxetine in human plasma. J Chromatogr 1999;50:423-7.  Back to cited text no. 9      
10.Maanni A, Combourieu I, Bonini M, Creppy EE. Fluoxetine, an antidepressant, and norfluoxetine, its metabolite, determined by HPLC with a C8 column and ultraviolet detection. J Clin Chem 1993;39:1749-50.  Back to cited text no. 10      
11.Green R, Houghton R, Scarth J, Gregory C. Determination of fluoxetine and its major active metabolite norfluoxetine in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr 2002;55:133-66.  Back to cited text no. 11      
12.Berzas JJ, Guiberteau C, Contento AM, Rodriguez V. Sensitive and rapid high-performance liquid chromatographic method for simultaneous determination of antidepressants in pharmaceutical formulations. J Chromatogr 2002;56:545-51.  Back to cited text no. 12      
13.Juan H, Zhiling Z, Huande L. Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI). J Chromatogr B 2005;820:33-9.  Back to cited text no. 13      
14.Berzas Nevado JJ, Villasen Llerena MJ, Contento Salcedo AM, Aguas Nuevo E. Determination of fluoxetine, fluvoxamine, and clomipramine in pharmaceutical formulations by capillary gas chromatography. J Chromatogr Sci 2000;38:200-6.  Back to cited text no. 14      
15.Indian Pharmacopoeia, Vol. II. Ghaziabad: Indian Pharmacopoeia Commission; 2007. p. 1471.  Back to cited text no. 15      
16.Krebs A, Starczewska B, Puzanowska-Tarasiewicz H, Sledz J. Spectrophotometric determination of olanzapine by its oxidation with N-bromosuccinimide and cerium (IV) sulphate. Anal Sci 2006;22:829-33.  Back to cited text no. 16  [PUBMED]  [FULLTEXT]  
17.Raggi MA, Casamenti G, Mandrioli R, Izzo G, Kenndler E. Determination of the novel antipsychotic drug olanzapine in human plasma using HPLC with amperometric detection. J Pharm Biomed Anal 2000;23:973-81.  Back to cited text no. 17  [PUBMED]  [FULLTEXT]  
18.Jasinska A, Starczewska B, Polkowska M, Puzanowska Tarasiewicz H. Solid phase extraction of olanzapine with reverse phase sorbents prior to UV and HPLC analysis. Anal Lett 2005;38:815-24.  Back to cited text no. 18      
19.Raggi MA, Casamenti G, Mandrioli R, Fanali S, Ronchi DD, Volterra V. Determination of the novel antipsychotic drug olanzapine in human plasma using HPLC with amperometric detection. J Chromatogr 2000;51:562-6.  Back to cited text no. 19      
20.Llorca PM, Coudore F, Corpelet C, Buyens A, Hoareau M, Eschalier A. Integration of olanzapine determinations in a HPLC-diode array detection system for routine psychotropic drug monitoring. J Clin Chem 2001;47:1719-21.  Back to cited text no. 20      
21.Berna M, Ackermann B, Ruterbories K, Glass S. Determination of olanzapine in human blood by liquid chromatography-tandem mass spectrometry. J Chromatogr B 2002;767:163-8.  Back to cited text no. 21      
22.Shah CR, Shah NJ, Suhagia BN, Patel NM. Simultaneous assay of olanzapine and fluoxetine in tablets by column high-performance liquid chromatography and high-performance thin-layer chromatography. J AOAC Int 2007;90:1573-8.  Back to cited text no. 22  [PUBMED]  [FULLTEXT]  
23.Reddy BV, Reddy KVNS, Sreeramulu J, Kanumula GV. Simultaneous determination of olanzapine and fluoxetine by HPLC. J Chromatogr 2007;66:111-4.  Back to cited text no. 23      


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]

This article has been cited by
1 Convolution of Emission Derivative Ratio Curves of Closely Related Fluorescent Reaction Products Using Discrete Fourier Functions and Non-Parametric Linear Regression Method
Marwa A. A. Ragab,Eman I. EL-Kimary
Journal of Fluorescence. 2014;
[Pubmed]
2 Isocratic High-Performance Liquid Chromatographic Assay of Olanzapine: Method Development and Validation
K. Basavaiah,N. Rajendraprasad,K. B. Vinay
ISRN Analytical Chemistry. 2014; 2014: 1
[Pubmed]
3 Simultaneous determination of olanzapine and fluoxetine hydrochloride in capsules by spectrophotometry, TLC-spectrodensitometry and HPLC
Mahmoud A. Tantawy,Nagiba Y. Hassan,Nariman A. Elragehy,Mohamed Abdelkawy
Journal of Advanced Research. 2013; 4(2): 173
[Pubmed]
4 Simultaneous determination of olanzapine and fluoxetine hydrochloride in pharmaceutical formulations by derivative spectrophotometry | [Determinação simultânea de olanzapina e cloridrato de fluoxetina em formulações farmacêuticas por espectrofotometria derivativa]
De Moura, J.I., Moita, G.C.
Quimica Nova. 2012; 35(3): 627-633
[Pubmed]
5 Utility of N-bromosuccinimide as an environmental-friendly reagent for sensitive determination of olanzapine in pharmaceuticals
Basavaiah, K., Abdulrahman, S.A.M.
Jordan Journal of Pharmaceutical Sciences. 2011; 4(3): 209-221
[Pubmed]
6 Quantitative determination of fluoxetine in human serum by high performance thin layer chromatography
Sigrid Mennickent, Ricardo Fierro, Mario Vega, Marta De Diego, C. Gloria Godoy
Journal of Separation Science. 2010; 33(14): 2206
[VIEW]



 

Top
Print this article  Email this article
 
  Search
   
   Next article
   Previous article 
   Table of Contents
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Article in PDF (849 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
    Acknowledgements
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed2886    
    Printed97    
    Emailed4    
    PDF Downloaded367    
    Comments [Add]    
    Cited by others 6    

Recommend this journal